TerrAscend is thrilled to announce a significant milestone with a fresh infusion of $140,000,000 in funding—a testament to our innovative vision and the robust confidence of our investors. As a leading TSX-listed cannabis company with extensive interests across the North American cannabis market, this capital injection positions us to accelerate our growth in both the medical and legal adult-use arenas. With our strong foothold in key regions such as Pennsylvania, New Jersey, Maryland, Michigan, and California, alongside our retail presence in Canada through flagship locations like The Apothecarium and Gage, we are committed to delivering industry-leading quality. This funding will enable us to further enhance our vertically integrated operations, spanning scaled cultivation, processing, and manufacturing facilities, ensuring that our cultivation and manufacturing practices continue to yield consistent, high-quality cannabis products that set new benchmarks in the industry.
In addition to expanding our core capabilities, the new capital will support strategic investments in research and development, technology advances, and market expansion initiatives. We plan to drive innovation across our portfolio of synergistic businesses and brands, including Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. By leveraging this robust financial backing, TerrAscend is poised to deepen its market penetration, broaden its product selection, and support community and regulatory engagement efforts that benefit both our customers and stakeholders. This is not just a funding announcement—it’s a renewed commitment to quality, excellence, and the sustainable future of the cannabis industry, reinforcing our promise to lead, innovate, and elevate the consumer experience across all our operations.
.png&w=3840&q=75)
